Beth Ashbridge

ID: 1b83f0dd-2619-30fb-68c4

/

Unclaimed

/

Organization: Goodwin Procter

Insulin Updates: March 2023

Big Molecule Watch · March 22, 2023

PTAB Institutes Mylan’s Two EYLEA (aflibercept) IPRs

Big Molecule Watch · January 13, 2023

Celltrion Obtains Canadian Approval To Sell Bevacizumab Biosimilar

Big Molecule Watch · January 13, 2023

Celltrion and Rani Therapeutics to Jointly Develop Oral Formulation of Ustekinumab Biosimilar

Big Molecule Watch · January 10, 2023

Pfizer Acquires Biologics Company To Expand Its Oncology Pipeline

Big Molecule Watch · September 1, 2021